We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 66

EU publishes detailed criteria for justification of cosmetic claims
  • Sidley Austin LLP
  • European Union
  • July 11 2013

Detailed EU requirements regarding the use of cosmetic product claims were published on 11 July 2013, the same day that the EU Cosmetic Products


Sidley Austin LLP global pricing newsletter - volume three 2014
  • Sidley Austin LLP
  • Brazil, Canada, China, European Union, France, Germany, India, United Kingdom, USA
  • April 15 2014

On October 21, 2013, Brazil’s National Agency of Supplemental Health enacted Normative Resolution 388, which mandated that all private healthcare


European Commission proposes new rules for novel foods
  • Sidley Austin LLP
  • European Union
  • January 22 2014

The European Commission recently adopted a proposal for a new EU Regulation on novel foods, which - if adopted - will streamline and simplify the


New EU food labeling rules adopted
  • Sidley Austin LLP
  • European Union
  • October 11 2011

On 29 September 2011, the Council of the European Union adopted a new EU Regulation which overhauls the existing food labeling regime and imposes additional food labeling requirements aimed at providing more and better information for consumers


Updates on international pricing issues for pharmaceutical and biologic products
  • Sidley Austin LLP
  • China, European Union, France, Germany, United Kingdom, USA
  • May 18 2012

Sidley Austin LLP’s Global Life Sciences Team is pleased to provide you with this Global Pricing Newsletter, the first in a periodic series updating clients and friends of the firm on pricing issues around the world that may have an impact on pharmaceutical and biologic manufacturers’ legal and business strategies


European Parliament calls for additional medical device safety measures
  • Sidley Austin LLP
  • European Union
  • June 18 2012

On 14 June 2012, the European Parliament (“EP”) adopted a Resolution calling on EU Member States and the European Commission to introduce and implement new measures aimed at ensuring the safety of medical devices


New EU rules recognize tolerance level for traces of GM material in feed
  • Sidley Austin LLP
  • European Union
  • July 21 2011

On 15 July, new rules entered into force in the EU that for the first time recognize a de facto tolerance level for traces of certain unauthorized genetically modified (“GM”) material in feed


EU court rejects national requirement for GM crop coexistence measures
  • Sidley Austin LLP
  • European Union
  • September 26 2012

On 6 September 2012, the Court of Justice of the European Union (CJEU) issued an important ruling in a case referred to it by Italy’s highest administrative court, the Consliglio di Stato


Extended scope EU Penalties Regulation enters into force
  • Sidley Austin LLP
  • European Union
  • July 13 2012

As of 2 July 2012, infringements of the EU’s paediatric and new pharmacovigilance rules fall within the scope of the revised EU Penalties Regulation and are now subject to financial penalties of up to 5 percent of the marketing authorization holder’s annual EU turnover


Opportunities to comment on the implementation of the EU Falsified Medicines Directive
  • Sidley Austin LLP
  • European Union
  • January 31 2012

The European Commission is currently taking the necessary steps to implement the provisions of the EU Falsified Medicines Directive (201162EU), published on 1 July 2011 and amending the EU Medicinal Products Directive (200183EC